Leveraging Cross-Linking Mass Spectrometry for Modeling Antibody-Antigen Complexes

Elucidating antibody-antigen complexes at the atomic level is of utmost interest for understanding immune responses and designing better therapies. Cross-linking mass spectrometry (XL-MS) has emerged as a powerful tool for mapping protein-protein interactions, suggesting valuable structural insights. However, the use of XL-MS studies to enable epitope/paratope mapping of antibody-antigen complexes is still limited up to now. XL-MS data can be used to drive integrative modeling of antibody-antigen complexes, where cross-links information serves as distance restraints for the precise determination of binding interfaces. In this approach, XL-MS data are employed to identify connections between binding interfaces of the antibody and the antigen, thus informing molecular modeling. Current literature provides minimal input about the impact of XL-MS data on the integrative modeling of antibody-antigen complexes. Here, we applied XL-MS to retrieve information about binding interfaces of three antibody-antigen complexes. We leveraged XL-MS data to perform integrative modeling using HADDOCK (active-passive residues and distance restraints strategies) and AlphaLink2. We then compared these three approaches with initial predictions of investigated antibody-antigen complexes by AlphaFold Multimer. This work emphasizes the importance of cross-linking data in resolving conformational dynamics of antibody-antigen complexes, ultimately enhancing the design of better protein therapeutics and vaccines.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:23

Enthalten in:

Journal of proteome research - 23(2024), 3 vom: 01. März, Seite 1049-1061

Sprache:

Englisch

Beteiligte Personen:

Di Ianni, Andrea [VerfasserIn]
Di Ianni, Alessio [VerfasserIn]
Cowan, Kyra [VerfasserIn]
Barbero, Luca M [VerfasserIn]
Sirtori, Federico Riccardi [VerfasserIn]

Links:

Volltext

Themen:

Antigen-Antibody Complex
Biotherapeutics
Cross-linking mass spectrometry
Data-driven integrative modeling
Drug discovery and development
Epitope/paratope mapping
Journal Article

Anmerkungen:

Date Completed 04.03.2024

Date Revised 04.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.jproteome.3c00816

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368628337